v3.26.1
Fair value of financial instruments
6 Months Ended
Jun. 30, 2026
Disclosure of fair value measurement of assets [abstract]  
Fair value of financial instruments Fair value of financial instruments
This note should be read in conjunction with Note 17, Fair value of financial instruments of the Barclays PLC Annual Report
2025 which provides more detail regarding accounting policies adopted, valuation methodologies used in calculating fair
value and the valuation control framework which governs oversight of valuations. There have been no changes in the
accounting policies adopted in the period. During the period, the Group further enhanced its fair value levelling framework.
These enhancements enabled a more granular assessment of input observability and a broader application of significance
assessments in determining the fair value hierarchy classification of financial instruments.
Valuation
The following table shows the Group’s assets and liabilities that are held at fair value disaggregated by the fair value
hierarchy and balance sheet classification:
Assets and liabilities held at fair value
Valuation techniques used
Quoted market
prices
Observable
inputs
Significant
unobservable inputs
Level 1
Level 2
Level 3
Total
As at 30.06.26
£m
£m
£m
£m
Trading portfolio assets
129,002
72,322
8,778
210,102
Financial assets at fair value through the income statement
6,666
201,409
5,025
213,100
Derivative financial instruments
61
301,565
1,976
303,602
Financial assets at fair value through other comprehensive income
55,653
24,918
2,441
83,012
Investment property
42
42
Total assets
191,382
600,214
18,262
809,858
Trading portfolio liabilities
(63,674)
(14,652)
(79)
(78,405)
Financial liabilities designated at fair value
(1,678)
(317,749)
(2,498)
(321,925)
Derivative financial instruments
(47)
(288,883)
(2,855)
(291,785)
Total liabilities
(65,399)
(621,284)
(5,432)
(692,115)
As at 31.12.25
Trading portfolio assets
111,158
68,556
10,347
190,061
Financial assets at fair value through the income statement
5,140
173,140
8,577
186,857
Derivative financial instruments
108
250,639
1,712
252,459
Financial assets at fair value through other comprehensive income
51,717
19,578
3,099
74,394
Investment property
43
43
Total assets
168,123
511,913
23,778
703,814
Trading portfolio liabilities
(42,917)
(14,733)
(87)
(57,737)
Financial liabilities designated at fair value
(1,702)
(287,532)
(4,874)
(294,108)
Derivative financial instruments
(93)
(237,650)
(3,065)
(240,808)
Total liabilities
(44,712)
(539,915)
(8,026)
(592,653)
The following table shows the Group’s Level 3 assets and liabilities that are held at fair value disaggregated by product type:
As at 30.06.26
Loans
Corporate
debt
Asset
backed
securities
Government
and
Government
sponsored
debt
Private
equity
investments
Issued
debt
Reverse
repurchase
and
repurchase
agreements
Interest
rate
derivatives
Equity
derivatives
Other
products
1
Total
£m
£m
£m
£m
£m
£m
£m
£m
£m
£m
£m
Trading
portfolio assets
3,156
1,873
1,670
1,342
737
8,778
Financial assets
at fair value
through the
income
statement
2,979
465
271
33
1,183
94
5,025
Derivative
financial
instruments
942
289
745
1,976
Financial assets
at fair value
through other
comprehensive
income
2,192
227
11
7
4
2,441
Investment
property
42
42
Total assets
8,327
2,565
1,952
1,382
1,187
942
289
1,618
18,262
Trading
portfolio
liabilities
(46)
(4)
(29)
(79)
Financial
liabilities
designated at
fair value
(20)
(2,397)
(81)
(2,498)
Derivative
financial
instruments
(1,436)
(424)
(995)
(2,855)
Total liabilities
(46)
(4)
(20)
(2,397)
(1,436)
(424)
(1,105)
(5,432)
As at 31.12.25
Loans
Corporate
debt
Asset
backed
securities
Government
and
Government
sponsored
debt
Private
equity
investments
Issued
debt
Reverse
repurchase
and
repurchase
agreements
Interest
rate
derivatives
Equity
derivatives
Other
products1
Total
£m
£m
£m
£m
£m
£m
£m
£m
£m
£m
£m
Trading
portfolio assets
5,667
1,849
874
1,513
444
10,347
Financial assets
at fair value
through the
income
statement
5,990
905
188
33
1,260
97
104
8,577
Derivative
financial
instruments
759
522
431
1,712
Financial assets
at fair value
through other
comprehensive
income
2,235
25
756
79
4
3,099
Investment
property
43
43
Total assets
13,892
2,779
1,818
1,625
1,264
97
759
522
1,022
23,778
Trading
portfolio
liabilities
(36)
(34)
(17)
(87)
Financial
liabilities
designated at
fair value
(20)
(3,760)
(887)
(207)
(4,874)
Derivative
financial
instruments
(612)
(1,602)
(851)
(3,065)
Total liabilities
(36)
(34)
(20)
(3,760)
(887)
(612)
(1,602)
(1,075)
(8,026)
1 Other products include certificate of deposits, funds and fund-linked products, equity cash products, investment property, credit derivatives and
foreign exchange derivatives.
Assets and liabilities transferred between Level 1 and Level 2
During the six-month period ended 30 June 2026, there were no assets or liabilities transferred between Level 1 and Level 2
(year ended 31 December 2025: £42.7bn assets and £(9.9)bn liabilities transferred from Level 2 to Level 1).
Level 3 movement analysis
The following table summarises the movements in the Level 3 balances during the six-month period. Transfers have been
reflected as if they had taken place at the beginning of the period.
Assets and liabilities transferred between Level 2 and Level 3 primarily reflect the application of the enhanced fair value
levelling framework, including refinements to observability assessments and significance testing methodologies, together
with the reassessment of fair value hierarchy classifications at the reporting date. Transfers include £4.7bn assets and
£(2.3)bn liabilities transferred from Level 3 to Level 2 reflecting these enhancements.
Analysis of movements in Level 3 assets and liabilities
As at
01.01.26
Total gains and
(losses) in the
period recognised
in the income
statement
Total gains
and
(losses) in
the period
recognised
in OCI
Transfers
As at
30.06.26
Purchases
Sales
Issues
Settlements
Trading
income2
Other
income
In
Out
£m
£m
£m
£m
£m
£m
£m
£m
£m
£m
£m
Trading portfolio
assets
10,347
4,116
(2,052)
(2,133)
35
586
(2,121)
8,778
Financial assets at fair
value through the
income statement
8,577
1,472
(1,212)
(1,164)
(35)
17
31
(2,661)
5,025
Financial assets at fair
value through other
comprehensive
income
3,099
466
(246)
(953)
8
146
(79)
2,441
Investment property
43
(1)
42
Trading portfolio
liabilities
(87)
(62)
41
12
(15)
32
(79)
Financial liabilities
designated at fair
value
(4,874)
(1,278)
504
67
(265)
3,348
(2,498)
Net derivative
financial instruments1
(1,353)
(495)
64
104
1
(79)
879
(879)
Total
15,752
5,497
(3,405)
(1,278)
(3,746)
190
18
404
(602)
12,830
As at
01.01.25
Total gains and
(losses) in the
period recognised
in the income
statement
Total gains
and
(losses) in
the period
recognised
in OCI
Transfers
As at
30.06.25
Purchases
Sales
Issues
Settlements
Trading
income2
Other
income
In
Out
£m
£m
£m
£m
£m
£m
£m
£m
£m
£m
£m
Trading portfolio
assets
10,115
4,125
(3,524)
(1,147)
136
439
(265)
9,879
Financial assets at fair
value through the
income statement
8,424
2,469
(1,200)
(573)
(75)
8
63
(285)
8,831
Financial assets at fair
value through other
comprehensive
income
3,739
566
(1,447)
(6)
2
29
307
(12)
3,178
Investment property
9
33
42
Trading portfolio
liabilities
(395)
(46)
28
37
(57)
9
(424)
Financial liabilities
designated at fair
value
(3,258)
91
(617)
31
88
(179)
996
(2,848)
Net derivative
financial instruments1
(1,104)
(17)
249
166
3
(34)
(135)
(872)
Total
17,530
7,130
(5,803)
(617)
(1,695)
354
40
539
308
17,786
1The derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets were £1,976m (June 2025:
£1,989m) and derivative financial liabilities were £(2,855)m (June 2025: £(2,861)m).
2Trading income represents gains and losses on Level 3 financial instruments which in the majority are offset by losses and gains on financial
instruments disclosed in Level 2.
Unrealised gains and losses on Level 3 assets and liabilities
The following table discloses the unrealised gains and losses recognised in the six-month period arising on Level 3 assets
and liabilities held at the period end.
Half year ended 30.06.26
Half year ended 30.06.25
Income statement
Other
comprehensive
income
Total
Income statement
Other
comprehensive
income
Total
Trading
income1
Other
income
Trading
income1
Other
income
£m
£m
£m
£m
£m
£m
£m
£m
Trading portfolio assets
26
26
21
21
Financial assets at fair value
through the income statement
(46)
18
(28)
(74)
7
(67)
Financial assets at fair value
through other comprehensive
income
8
8
1
28
29
Investment property
Trading portfolio liabilities
12
12
34
34
Financial liabilities designated at
fair value
70
70
87
87
Net derivative financial
instruments
104
1
105
164
3
167
Total
174
19
193
233
38
271
1Trading income represents gains and losses on Level 3 financial instruments which in the majority are offset by losses and gains on financial
instruments disclosed in Level 2.
Valuation techniques and sensitivity analysis
Sensitivity analysis is performed on products with significant unobservable inputs (Level 3) to generate a range of reasonably
possible alternative valuations. The sensitivity methodologies applied take account of the nature of valuation techniques
used, as well as the availability and reliability of observable proxy and historical data and the impact of using alternative
models. These methodologies primarily leverage the prudent valuation framework when determining sensitivities.
Sensitivities are based on either range or spread data from reliable reference source or a scenario based on relevant market
analysis alongside the impact of using alternative models. Sensitivities are calculated without reflecting the impact of any
diversification in the portfolio.
The valuation and sensitivity methodologies applied in the current period are consistent with those described in Note 17, Fair
value of financial instruments, in the Barclays PLC Annual Report 2025.
Sensitivity analysis of valuations using unobservable inputs (Relates to Level 3 Portfolios)
As at 30.06.26
As at 31.12.25
Favourable changes
Unfavourable changes
Favourable changes
Unfavourable changes
Income
statement
Equity
Income
statement
Equity
Income
statement
Equity
Income
statement
Equity
£m
£m
£m
£m
£m
£m
£m
£m
Loans
187
3
(229)
(40)
245
21
(324)
(37)
Corporate debt
72
(87)
88
(68)
Asset backed securities
110
1
(88)
(1)
51
6
(43)
(6)
Government and Government
sponsored debt
55
(53)
45
(41)
Private equity investments
210
(210)
218
1
(218)
(1)
Interest rate derivatives
127
(131)
109
(134)
Equity derivatives
375
(375)
336
(336)
Other products1
60
21
(61)
(34)
109
312
(108)
(89)
Total
1,196
25
(1,234)
(75)
1,201
340
(1,272)
(133)
1Other products include issued debt, certificate of deposits, funds and fund-linked products, equity cash products, reverse repurchase and
repurchase agreements, credit derivatives and foreign exchange derivatives.
The effect of stressing unobservable inputs to a range of reasonably possible alternatives, alongside considering the impact
of using alternative models, would be to increase fair values by up to £1,221m (December 2025: £1,541m) or to decrease
fair values by up to £1,309m (December 2025: £1,405m) with substantially all of the potential effect impacting profit and
loss rather than reserves.
Significant unobservable inputs
The valuation techniques and significant unobservable inputs for Level 3 assets and liabilities recognised at fair value are
broadly consistent with Note 17, Fair value of financial instruments in the Barclays PLC Annual Report 2025.
Fair value adjustments
Key balance sheet valuation adjustments are quantified below:
As at
30.06.26
As at
31.12.25
£m
£m
Exit price adjustments derived from market bid-offer spreads
(715)
(628)
Uncollateralised derivative funding
49
62
Derivative credit valuation adjustments
(162)
(155)
Derivative debit valuation adjustments
103
119
Unrecognised gains as a result of the use of valuation models using unobservable inputs
The amount that is yet to be recognised in income, relating to the difference between the transaction price (the fair value at
initial recognition) and the amount that would have arisen had valuation models using unobservable inputs been used on
initial recognition, is £227m (December 2025: £264m) for financial instruments measured at fair value. These unrecognised
gains decreased by amortisation and releases of £73m (December 2025: £64m) partly offset by additions and FX revaluation
of £36m (December 2025: £55m). For financial instruments carried at amortised cost, the amount that is yet to be
recognised in income is £163m (December 2025: £164m). There are amortisation and releases of £6m (December 2025:
£9m) offset by additions of £5m (December 2025: £nil).
Third party credit enhancements
Structured and brokered certificates of deposit issued by the Group are insured up to $250,000 per depositor by the Federal
Deposit Insurance Corporation (FDIC) in the United States. The FDIC is funded by fees that Barclays and other banks pay for
deposit insurance coverage. The carrying value of these issued certificates of deposit that are designated under the IFRS 9
fair value option includes this third-party credit enhancement. The on-balance sheet value of these brokered certificates of
deposit amounted to £1,948m (December 2025: £4,156m).
Comparison of carrying amounts and fair values for assets and liabilities not held at fair value
Valuation methodologies employed in calculating the fair value of financial assets and liabilities not held at fair value are
consistent with those described within Note 17, Fair value of financial instruments in the Barclays PLC Annual Report 2025.
The following table summarises the fair value of financial assets and liabilities not held at fair value on the Group’s balance
sheet:
As at 30.06.26
As at 31.12.25
Carrying
amount
Fair value
Carrying
amount
Fair value
Financial assets
£m
£m
£m
£m
Debt securities at amortised cost
73,519
72,595
68,475
67,442
Loans and advances at amortised cost
371,301
368,550
361,523
361,517
Reverse repurchase agreements and other similar secured lending
12,100
12,100
17,622
17,622
Assets included in disposal groups classified as held for sale
5,801
6,065
Financial liabilities
Deposits at amortised cost
(594,357)
(594,358)
(585,613)
(585,689)
Repurchase agreements and other similar secured borrowing
(30,704)
(30,704)
(25,170)
(25,170)
Debt securities in issue
(126,837)
(129,065)
(119,033)
(121,439)
Subordinated liabilities
(11,098)
(11,571)
(12,954)
(13,483)